Ledger.Open graph →
SEC Form D · filed September 28, 2016

GALECTIN THERAPEUTICS INC

Offering
$12.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORCROSS, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Marc G. Rubin · Norcross, GADirectorGilbert F. Amelio · Norcross, GADirectorJames C. Czirr · Norcross, GADirectorPeter G. Traber · Norcross, GAExec · DirectorArthur R. Greenberg · Norcross, GADirectorSteven G. Prelack · Norcross, GADirectorJack W. Callicutt · Norcross, GAExec · DirectorJohn G. Mauldin · Norcross, GADirectorKevin D. Freeman · Norcross, GADirectorGilbert S. Omenn · Norcross, GADirectorPaul A. Zweng · VANCOUVER, British Columbia, CanadaDirectorScott Brady · Redwood City, CADirectorMargo J. Georgiadis · EMERYVILLE, CAExec · DirectorMark Cupta · Redwood City, CAExec · DirectorRoisin W. Addlestone · Grand Cayman, Cayman IslandsDirectorGregory Mulholland · Redwood City, CADirectorCarole J. Piwnica · EMERYVILLE, CADirectorJohn F. Morgan, Jr · Hilton Head Island, SCExec · DirectorJohn F. Morgan, Sr · Hilton Head Island, SCDirectorThomas A. Burkhart · Reno, NVDirectorScott A. Heffernan · Vancouver, British Columbia, CanadaDirectorWayne A. Johnstone · Vancouver, British Columbia, CanadaExec · DirectorBrenda A. Nowak · Vancouver, British Columbia, CanadaDirectorFrederic G. Hewett · Vancouver, British Columbia, CanadaDirectorJames A. Dawson · Vancouver, British Columbia, CanadaDirectorCharles L. Baxter · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗